With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems …

Aug 29, 2024 · A look at the shareholders of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) can tell us which group is most powerful. With 45% stake, institutions possess the maximum shares in …

45%
OFF

With 45% Stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Seems …

1 week from now

Aug 29, 2024 · A look at the shareholders of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) can tell us which group is most powerful. With 45% stake, institutions possess the maximum shares in …

yahoo.com

47%
OFF

Owning 47% Shares,institutional Owners Seem Interested In Rigel ...

1 week from now

Mar 6, 2024 · Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), [email protected] (Simply Wall St) Wed, Mar 6, 2024, …

yahoo.com

$0.06
OFF

Rigel Pharmaceuticals (RIGL) Stock Price, News & Analysis

1 week from now

Jan 10, 2025 · Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced its quarterly earnings data on Tuesday, August, 6th. The biotechnology company reported ($0.06) earnings per …

marketbeat.com

$3.74
OFF

State Street Cuts Stake In Rigel Pharmaceuticals (RIGL)

1 week from now

As of February 5, 2023, the average one-year price target for Rigel Pharmaceuticals is $3.74. The forecasts range from a low of $0.91 to a high of $15.75. The forecasts range from a low of …

nasdaq.com

1%
OFF

Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved …

1 week from now

Oct 10, 2024 · In recent months, Rigel Pharmaceuticals (NASDAQ:RIGL) has surged by nearly 50.1% since July.RIGL’s strength lies in its successful execution, innovative portfolio, strategic …

seekingalpha.com

$17
OFF

Rigel Pharmaceuticals Stock Hits 52-week High At $17.5

1 week from now

Nov 8, 2024 · Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) stock soared to a 52-week high, reaching a price level of $17.5, marking a significant milestone for the company.This peak …

investing.com

$3.74
OFF

Fmr Cuts Stake In Rigel Pharmaceuticals (RIGL) - Nasdaq

1 week from now

As of February 8, 2023, the average one-year price target for Rigel Pharmaceuticals is $3.74. The forecasts range from a low of $0.91 to a high of $15.75. The forecasts range from a low of …

nasdaq.com

$25
OFF

Rigel Pharmaceuticals Price Target Raised To $25 From $15 At

1 week from now

Dec 10, 2024 · Cantor Fitzgerald raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $25 from $15 and keeps a Neutral rating on the shares. Rigel announced initial data from the …

nasdaq.com

$23
OFF

Rigel Pharmaceuticals Price Target Raised To $23 From $15 At Piper ...

1 week from now

Nov 14, 2024 · Piper Sandler analyst Allison Bratzel raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $23 from $15 driven by pipeline developments. The firm keeps a …

nasdaq.com

FAQs about With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems … Coupon?

Who owns Rigel Pharmaceuticals (Rigel) stock?

In the past three months, Rigel Pharmaceuticals insiders have not sold or bought any company stock. Only 9.04% of the stock of Rigel Pharmaceuticals is held by insiders. 66.23% of the stock of Rigel Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company. ...

Who controls Rigel Pharmaceuticals (Rigl)?

If you want to know who really controls Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ), then you'll have to look at the makeup of its share registry. With 47% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). ...

What was Rigel Pharmaceuticals' stock price in 2024?

Rigel Pharmaceuticals' stock was trading at $14.50 at the beginning of 2024. Since then, RIGL stock has increased by 13.8% and is now trading at $16.50. How were Rigel Pharmaceuticals' earnings last quarter? Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced its quarterly earnings results on Tuesday, August, 6th. ...

Should you buy Rigel Pharmaceuticals (Rigl)?

Rigel Pharmaceuticals is a commercial-stage biotechnology company developing innovative treatments for hematologic disorders and cancer. Since my initial article in July, in which I rated RIGL a “Strong Buy,” the stock has rallied by about 50.1%. Yet, I believe RIGL still looks like a compelling investment. ...

Do insiders own Rigel Pharmaceuticals?

However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions. Our most recent data indicates that insiders own some shares in Rigel Pharmaceuticals, Inc.. In their own names, insiders own US$2.7m worth of stock in the US$232m company. ...

Does FMR own Rigel Pharmaceuticals?

FMR LLC now owns 48,105 shares of the biotechnology company’s stock worth $778,000 after buying an additional 26,184 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its stake in Rigel Pharmaceuticals by 29.7% during the third quarter. ...